CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230,845
- in 7 filings, $1.6M under 10b5-1 plans
Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-23 | Schwab Andrew J. Director | Grant or award · Stock Option (right to buy) | +27,567 | 27,567 | ||
| 2023-02-23 | Phillips Andrew John Director | Grant or award · Stock Option (right to buy) | +27,567 | 27,567 | ||
| 2023-02-23 | Heyman Richard A. Director | Grant or award · Stock Option (right to buy) | +34,458 | 34,458 | ||
| 2023-02-23 | Gupta Rishi Director | Grant or award · Stock Option (right to buy) | +27,567 | 27,567 | ||
| 2023-02-23 | Derynck Mika K Director | Grant or award · Stock Option (right to buy) | +27,567 | 27,567 | ||
| 2023-02-23 | Bauer Jake Director | Grant or award · Stock Option (right to buy) | +27,567 | 27,567 | ||
| 2023-02-23 | Ballal Rahul D. Director | Grant or award · Stock Option (right to buy) | +27,567 | 27,567 | ||
| 2023-02-23 | COMMODORE CAPITAL LP 10% owner | Purchase | +621.75 | $22.07 | $14K | 718,749 |
| 2023-02-23 | COMMODORE CAPITAL LP 10% owner | Other acquisition | +729,891 | 1,448,640 | ||
| 2023-02-23 | Schwab Andrew J. Director | Grant or award | +4,838,092 | 4,838,092 | ||
| 2023-02-23 | Schwab Andrew J. Director | Grant or award | +960,383 | 960,383 | ||
| 2023-02-23 | Heyman Richard A. Director | Grant or award | +149,820 | 149,820 | ||
| 2023-02-23 | Heyman Richard A. Director | Grant or award | +37,407 | 37,407 | ||
| 2023-02-23 | Heyman Richard A. Director | Grant or award | +31,172 | 31,172 | ||
| 2023-02-23 | Heyman Richard A. Director | Grant or award · Employee Stock Option (right to buy) | +20,657 | 20,657 | ||
| 2023-02-23 | Gupta Rishi Director | Grant or award | +7,611,458 | 7,611,458 | ||
| 2023-02-23 | Gupta Rishi Director | Grant or award | +288,114 | 288,114 | ||
| 2023-02-23 | Bauer Jake Director | Grant or award | +87,372 | 87,372 | ||
| 2023-02-23 | Bauer Jake Director | Grant or award · Stock Option | +17,706 | 17,706 | ||
| 2023-02-23 | Derynck Mika K Director | Grant or award · Employee Stock Option (right to buy) | +87,373 | 87,373 |
Page 31 of 37 · 724 trades